Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)

  • End date
    May 1, 2023
  • participants needed
  • sponsor
    Dr. F. Köhler Chemie GmbH
Updated on 7 February 2022
organ transplantation
kidney transplant


Synopsis Title of Study A prospective, randomized, single blind multicentre phase III study on organ preservation with Custodiol-N compared with Custodiol solution in organ transplantation (kidney, liver and pancreas)

Protocol number: CL-N-KLP-TX-III/07-AT/17

Trial design The study design is a prospective, randomized, single blind, multicentre, phase III comparison study of organ perfusion intended to demonstrate non-inferiority of Custodiol-N against Custodiol in organ transplantation of kidney, combined kidney-pancreas and liver.

Intended duration of study The overall duration for the trial is expected to be approximately 30 months. The du-ration of the trial for each subject is expected to be 3 months (transplantation and a follow-up period of 90 days).

Purpose of the study

The objective of this investigation is to demonstrate non-inferiority of graft preservation with Custodiol-N compared to Custodiol with respect to both graft function and injury after transplantation of kidney, liver or combined kidney-pancreas.

Patient selection The study population will be selected from patients who will undergo kidney, liver or combined kidney-pancreas transplantation. Patients of each gender will be included in the study.

Planned number of patients (recipients)

In total N=614 including:

Kidney 412 (including approx. 30 combined kidney-pancreas)

Liver 202

Condition Kidney Failure, Liver Failure, Chronic, Kidney-Pancreas Failure
Treatment Custodiol-N Solution, Custodiol HTK Solution
Clinical Study IdentifierNCT03627013
SponsorDr. F. Köhler Chemie GmbH
Last Modified on7 February 2022


Yes No Not Sure

Inclusion Criteria

All organs (kidney, combined kidney - pancreas and liver) Donor criteria
deceased adult (18 years) donors fulfilling the criteria for organ donation Patient (recipient) criteria
recipients awaiting their transplant
recipients 18 years
recipients' signed informed consent before the transplantation Kidney / combined kidney - pancreas recipients
n/a Liver recipient
full organ transplantation

Exclusion Criteria

All organs (kidney, combined kidney - pancreas and liver) Donor criteria
donors whose organs are all allocated out of Austria
general refusal of organ donation
donation after cardiac death (DCD) Patient (recipient) criteria
pregnant or lactating patients
recipients participating in any interventional study (e.g. another study involving compound/interventions aimed at the reduction of preservation and / or ischemia / reperfusion injury)
all combined allocations other than pancreas and kidney
Kidney / combined kidney -pancreas recipient
double kidney transplantation
pancreas retransplantation
machine perfusion According to the KDIGO-Guidelines (2009) all patients with PRA >0% are excluded
Liver recipient
machine perfusion
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note